PDF herunterladen
Horm Metab Res 2016; 48(09): 601-606
DOI: 10.1055/s-0042-105153
Endocrine Research
© Georg Thieme Verlag KG Stuttgart · New York

The Transcriptional Regulation of FOXO Genes in Thyrocytes

F. Franz   *
1   Clinic of Endocrinology and Nephrology, Department of Internal Medicine, Neurology and Dermatology, University of Leipzig, Leipzig, Germany
,
C. Weidinger   *
1   Clinic of Endocrinology and Nephrology, Department of Internal Medicine, Neurology and Dermatology, University of Leipzig, Leipzig, Germany
,
K. Krause
1   Clinic of Endocrinology and Nephrology, Department of Internal Medicine, Neurology and Dermatology, University of Leipzig, Leipzig, Germany
,
O. Gimm
2   Department of General, Visceral, and Vascular Surgery, Martin-Luther-University of Halle-Wittenberg, Halle/Saale, Germany
,
H. Dralle
2   Department of General, Visceral, and Vascular Surgery, Martin-Luther-University of Halle-Wittenberg, Halle/Saale, Germany
,
D. Führer
3   Department of Endocrinology & Metabolism and Division of Laboratory Research, University Hospital Essen, Essen, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 01. März 2016

accepted 08. März 2016

Publikationsdatum:
03. Juni 2016 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

FOXO transcription factors are key regulators of DNA damage repair, proliferation and apoptosis in thyrocytes. Thyroid malignancies show impaired FOXO function. In this study, we investigated the transcriptional regulation of FOXO isoforms in thyroid epithelial cells. mRNA expression of FOXO isoforms (FOXO1, 3 and 4) was determined in FRTL-5 cells stimulated with different growth factors and H2O2. Furthermore, the impact of PI3K/AKT signalling on FOXO transcription was investigated in PI3K p110α mutant FRTL-5 cells and regulatory dependence of FOXO transcription on FOXO was studied in FRTL-5 cells with hFOXO3 overexpression. Finally, mRNA expression levels of FOXO isoforms were determined in human epithelial thyroid tumours. Growth factor deprivation induced transcription of FOXO1, 3 and 4, whereas insulin stimulation decreased FOXO1 and FOXO4 transcription in FRTL-5 cells. Inhibition of the PI3K/AKT cascade amplified FOXO1 and FOXO4 expression. In contrast, H2O2 and TSH did not influence FOXO transcription in thyrocytes. Overexpression of PI3K p110α inhibited FOXO3 and induced FOXO4 transcription. In human thyroid tumours, FOXO1 and FOXO3 mRNA levels were significantly downregulated in papillary thyroid carcinoma when compared to normal tissues. In contrast, follicular thyroid carcinomas showed significant upregulation of FOXO4 mRNA.

In this paper, we demonstrate an influence of PI3K signalling on FOXO transcription in thyrocytes. Moreover, we show that thyroid cancers exhibit alterations in FOXO transcription besides the previously reported alterations in posttranslational FOXO3 regulation. These findings may add to the concept of targeting the PI3K pathway in advanced thyroid cancers.

Key words

FOXO3 - FOXO1 - FOXO4 - thyroid carcinogenesis - PI3K/AKT

* These authors contributed equally to the manuscript


 

  • References

  • 1 Weidinger C, Krause K, Klagge A, Karger S, Fuhrer D. Forkhead box-O transcription factor: critical conductors of cancer’s fate. Endocr Relat Cancer 2009; 15: 917-929
    PubMedSuche in Google Scholar
  • 2 Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007; 7: 847-859
    CrossrefPubMedSuche in Google Scholar
  • 3 Paula-Gomes S, Gonçalves DA, Baviera AM, Zanon NM, Navegantes LC, Kettelhut IC. Insulin suppresses atrophy- and autophagy-related genes in heart tissue and cardiomyocytes through AKT/FOXO signaling. Horm Metab Res Issue 2013; 45: 849-855
    PubMedSuche in Google Scholar
  • 4 Weidinger C, Krause K, Fuhrer D. Novel insights into FOXOlogy: FOXOs and their putative role in thyroid carcinogenesis. Exp Rev Endocrinol Metab 2011; 6: 63-69
    PubMedSuche in Google Scholar
  • 5 Essaghir A, Dif N, Marbeant CY, Coffer PJ, Demoulin JB. The transcription of FOXO genes is stimulated by FOXO3 and repressed by growth factors. J Biol Chem 2007; 17: 10334-10342
    PubMedSuche in Google Scholar
  • 6 Guigon CJ, Zhao L, Willingham MC, Cheng SY. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer. Oncogene 2009; 28: 509-517
    CrossrefPubMedSuche in Google Scholar
  • 7 Karger S, Weidinger C, Krause K, Sheu SY, Aigner T, Gimm O, Schmid KW, Dralle H, Fuhrer D. FOXO3a: a novel player in thyroid carcinogenesis?. Endocr Relat Cancer 2009; 16: 189-199
    CrossrefPubMedSuche in Google Scholar
  • 8 Weidinger C, Krause K, Mueller K, Klagge A, Fuhrer D. FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide. J Clin Endocrinol Metab 2011; 96: E1361-E1371
    CrossrefPubMedSuche in Google Scholar
  • 9 Jung HS, Kim DW, Jo YS, Chung HK, Song JH, Park JS, Park KC, Park SH, Hwang JH, Jo KW, Shong M. Regulation of protein kinase B tyrosine phosphorylation by thyroid-specific oncogenic RET/PTC kinases. Mol Endocrinol 205 19: 2748-2759
    PubMed
  • 10 Klagge A, Weidinger C, Krause K, Jessnitzer B, Gutknecht M, Fuhrer D. The role of FOXO3 in DNA damage response in thyrocytes. Endocr Relat Cancer 2011; 18: 555-564
    CrossrefPubMedSuche in Google Scholar
  • 11 Ambesi-Impiombato FS, Parks LA, Coon HG. Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci U S A 1980; 77: 3455-3459
    CrossrefPubMedSuche in Google Scholar
  • 12 Klagge A, Krause K, Muller K, Haag J, Fuhrer D. High-efficient Nonviral Transfection of the Rat Thyroid Cell Line FRTL-5. Horm Metab Res 2010; 1: 897-899
    Thieme ConnectPubMedSuche in Google Scholar
  • 13 Muller K, Weidinger C, Fuhrer D. Insulin glargine and insulin have identical effects on proliferation and phosphatidylinositol 3-kinase/AKT signalling in rat thyrocytes and human follicular thyroid cancer cells. Diabetologia 2010; 53: 1001-1003
    CrossrefPubMedSuche in Google Scholar
  • 14 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 2001; 25: 402-408
    CrossrefPubMedSuche in Google Scholar
  • 15 Broecker-Preuss M, Baten J, Sheu-Grabellus SY, Görges R, Bockisch A, Schmid KW, Führer D, Mann K. Expression of the cAMP binding protein EPAC1 in thyroid tumors and growth regulation of thyroid cells and thyroid carcinoma cells by EPAC proteins. Horm Metab Res 2015; 47: 200-208
    Thieme ConnectPubMedSuche in Google Scholar
  • 16 Stokowy T, Wojtaś B, Fujarewicz K, Jarząb B, Eszlinger M, Paschke R. miRNAs with the potential to distinguish follicular thyroid carcinomas from benign follicular thyroid tumors: results of a meta-analysis. Horm Metab Res 2014; 46: 171-180
    Thieme ConnectPubMedSuche in Google Scholar
  • 17 Krause K, Prawitt S, Eszlinger M, Ihling C, Sinz A, Schierle K, Gimm O, Dralle H, Steinert F, Sheu SY, Schmid KW, Fuhrer D. Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma. Am J Pathol 2011; 179: 3066-3074
    CrossrefPubMedSuche in Google Scholar
  • 18 Xing M, Haugen BR, Schlumberger M. Progress in molecular-based management of differentiated thyroid cancer. Lancet 2013; 381: 1058-1069
    CrossrefPubMedSuche in Google Scholar